Hypoxic conditions are known to increase MV and exosome release from a variety of breast cancer cell lines, including MCF-7, MDA-MB-231, and SK-BR3 [43, 45], which requires hypoxia-inducible factor- (HIF-) dependent RAB22A expression [43]. Here, RAB22A is linked to breast cancer.